Hemigland Cryoablation of Localized Low, Intermediate and High Risk Prostate Cancer: Oncologic and Functional Outcomes at 5 Years COMMENT

被引：0
|
作者：
Chin, Joseph L. [1 ]
机构：
[1] Western Univ, Urol & Oncol, London, ON, Canada
来源：
JOURNAL OF UROLOGY | 2019年 / 202卷 / 06期
关键词：
D O I：
10.1097/01.JU.0000582668.13559.54
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1198 / 1198
页数：1
相关论文
共 50 条
  • [31] Stereotactic Body Radiotherapy for Localized Low-Intermediate Risk Prostate Cancer
    Haas, J.
    Santoro, M.
    Ashley, R.
    Mucciolo, R.
    Andrews, J.
    Clancey, O.
    Episcopia, K.
    Accordino, D.
    Sanchez, A.
    Witten, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S432 - S432
  • [32] Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland Cryoablation: A Prospective Cohort Study of Men With Intermediate-risk Prostate Cancer
    Wysock, James S.
    Rapoport, Eli
    Hernandez, Hunter
    Gogaj, Rozalba
    Lepor, Herbert
    JOURNAL OF UROLOGY, 2023, 210 (03): : 454 - 464
  • [33] Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent Disease
    Baskin, Avi
    Charondo, Leslie Bernal
    Balakrishnan, Ashwin
    Cowan, Janet E.
    Cooperberg, Matthew R.
    Carroll, Peter R.
    Nguyen, Hao
    Shinohara, Katsuto
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (10) : 451.e15 - 451.e20
  • [34] Sub-Castrate Testosterone Nadir and Clinical Outcomes in Intermediate or High-Risk Localized Prostate Cancer
    Hurmuz, Pervin
    Ozyigit, Gokhan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 224 - 225
  • [35] Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance
    Nyame, Yaw A.
    Almassi, Nima
    Haywood, Samuel C.
    Greene, Daniel J.
    Ganesan, Vishnu
    Dai, Charles
    Zabell, Joseph
    Reichard, Chad
    Arora, Hans
    Zampini, Anna
    Crane, Alice
    Hettel, Daniel
    Elshafei, Ahmed
    Fareed, Khaled
    Stein, Robert J.
    Berglund, Ryan K.
    Gong, Michael
    Jones, J. Stephen
    Klein, Eric A.
    Stephenson, Andrew J.
    JOURNAL OF UROLOGY, 2017, 198 (03): : 591 - 598
  • [36] Outcomes for Young Men With Localized Intermediate-Risk Prostate Cancer: An Analysis of the NCDB
    Chua, Samantha
    Qureshi, Muhammad M.
    Boyd, Graham
    Gignac, Gretchen A.
    Hirsch, Ariel E.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (05) : E531 - E542
  • [37] Molecular correlates of intermediate- and high-risk localized prostate cancer
    Ye, Huihui
    Sowalsky, Adam G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 368 - 374
  • [38] PRIMARY FOCAL CRYOABLATION FOR LOW-, INTERMEDIATE AND HIGH-RISK PROSTATE CANCER: OUTCOMES OF 180 PATIENTS IN MEDIAN OF 33 MONTHS FOLLOW UP.
    Oishi, Masakatsu
    Ashrafi, Akbar
    Cacciamani, Giovanni
    Gill, Inderbir
    Shin, Toshitaka
    Ukimura, Osamu
    Duke, Bahn K.
    Abreu, Andre
    JOURNAL OF UROLOGY, 2018, 199 (04): : E659 - E659
  • [39] Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
    Yong Luo
    Mingchuan Li
    Hengzhi Qi
    Jiahui Zhao
    Yili Han
    Yunhua Lin
    Zhu Hou
    Yongguang Jiang
    World Journal of Surgical Oncology, 16
  • [40] Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
    Luo, Yong
    Li, Mingchuan
    Qi, Hengzhi
    Zhao, Jiahui
    Han, Yili
    Lin, Yunhua
    Hou, Zhu
    Jiang, Yongguang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
12345